EMJ Hematology 10 [Supplement 5] . 2022

In this issue

This article covers multiple oral and poster presentations dedicated to gene therapy as a treatment for haemophilia A and B, which took place at the International Society on Thrombosis and Haemostasis (ISTH) Congress, 9th–13th July 2022. The article highlights updates from clinical trials of adeno-associated virus-based gene therapy products, guidance on the real-world monitoring of patients with haemophilia who have received gene therapy, and accentuates the unmet needs and challenges associated with gene therapy.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.